Pharma Cos. Get Cert. In MDL Over Generic Prograf Delays
A Massachusetts federal judge on Tuesday certified a class of pharmaceutical companies in multidistrict antitrust litigation that accuses Astellas Pharma US Inc. of keeping a generic version of its immunosuppressant Prograf...To view the full article, register now.
Already a subscriber? Click here to view full article